Compare Griptha Putra Persada Tbk. (GRPH) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Griptha Putra Persada Tbk. vs Merck Tbk. — how do they compare? Griptha Putra Persada Tbk. trades at Rp64 (market cap 63B, 3.04M 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Merck Tbk. is far larger — about 27.8× Griptha Putra Persada Tbk.'s market cap, and Griptha Putra Persada Tbk. is more actively traded (3.04M versus 29.1K). Which is the better fit depends on your goals.
| GRPH | MERK | |
|---|---|---|
Market Cap | 63B | 1.75T |
Volume | 3.04M | 29.1K |
Lot | 30.41K | 291 |
Turnover | 191.97M | 113.37M |
Average Price | 63.14 | 3,895.98 |
Value | 191.97M | 113.37M |
Indicative Equilibrium Price | 63 | 3,890 |
Indicative Equilibrium Volume | 700 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Griptha Putra Persada Tbk.
PT Griptha Putra Persada Tbk (the Company), was established based on Notarial Deed No. 26 dated April 14, 2010 of Drs. Ika Slamet Riyono, S.H., notary in Kudus. The Company started its commercial operation in July 1, 2015. The Company’s immediate parent company is PT Mulia Jaya Palma and the ultimate controlling shareholder of the Company is Samuel Jeffrey Christiawan Soegeng.
Read more on GRPH →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
